Advanced Therapeutics in Rheumatoid Arthritis (RA)
common.study.values.description
“Advanced Therapeutics in Rheumatoid Arthritis (RA)”
This study will evaluate the retention rates of two advanced therapies, Tumour Necrosis Factor (TNF) and Janus kinase inhibitor (JAK) in the treatment of adults with Rheumatoid Arthritis (RA) over a two year period. It will also examine the ability to embed a clinical trial in a clinical situation using an electronic medical record (EMR).
common.study.values.location
participant.ui.study.affiliations-map.online-study.header-virtual
participant.ui.study.affiliations-map.online-study.text
common.study.values.methods
common.study.methods.has-drugs-yes
common.study.methods.is-healthy-yes
Drug - Etanercept
injection
Drug - tofacitinib
tablet
participant.views.study.view.additional
participant.views.study.view.scientific-title
Advanced Therapeutics in Rheumatoid Arthritis (RA)
common.study.values.clinical-trial-id
NCT03976245
participant.views.study.view.id
ejR9ve
